Clinical Trial

Exercise During Pregnancy: Effects on the Maternal-Fetal Unit

Study acronym: PREGFIT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Metabolic alterations during pregnancy have been associated with adverse maternal-fetal outcomes, including low birth weight and pregnancy complications. Maternal endothelial dysfunction, oxidative stress, insulin resistance, and placental mitochondrial dysfunction are thought to contribute to fetal metabolic disturbances. Lifestyle changes, such as structured exercise during pregnancy, may modulate maternal and placental factors. This randomized controlled trial will evaluate the effects of a multicomponent exercise program during the second and third trimester on maternal functional capacity, vascular health, anthropometry, metabolic biomarkers, placental function, and newborn health outcomes.
Trial Details
NCT Number NCT07264231
Lead Sponsor Universidad Pública de Navarra
Collaborators: Fundación Instituto de Investigación Sanitaria de Navarra, NavarraBiomed Biomedical Research Center, Complejo Hospitalario de Navarra
Conditions Pregnancy
Enrollment 64 participants
Start Date 2025-09-01
Primary Completion 2027-12-15 (estimated)
Study Completion 2027-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-12-04